Loading market dashboard
Specificity, Inc.
SPTYCommunication ServicesOTCUS
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
ALAMEDA, Calif.--(BUSINESS WIRE)-- #CRISPR--Scribe Therapeutics reports preclinical data at ASGCT 2026 demonstrating enhanced potency and specificity of engineered CRISPR technologies.
Results demonstrate the superiority of Whole Genome Sequencing compared to methylation-based approaches IRVING, Texas, March 31, 2026 /PRNewswire/ -- Caris Life Sciences ® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced the finalized Achieve 1 Study results. These results represent a major milestone in Caris' goal to detect cancer earlier, through the future launch of Caris Detect™, its multi-cancer early detection (MCED) test.
New panel expands coverage for Alzheimer's and Parkinson's diseases including 15 new biomarkers developed with support from The Michael J. Fox Foundation for Parkinson's Research (MJFF) and 12 assays specific to brain and peripheral Tau isoforms
New panel expands coverage for Alzheimer's and Parkinson's diseases including 15 new biomarkers developed with support from The Michael J. Fox Foundation for Parkinson's Research (MJFF) and 12 assays specific to brain and peripheral Tau isoforms | NULISA™ data to be presented in over 11 scientific sessions and 25 posters at the International Conference on Alzheimer's & Parkinson's Diseases (AD/PD 2026) New panel expands coverage for Alzheimer's and Parkinson's diseases including 15 new biomarkers developed with support from The Michael J. Fox Foundation for Parkinson's Research (MJFF) and 12 assays specific to brain and peripheral Tau isoforms | NULISA™ data to be presented in over 11 scientific sessions and 25 posters at the International Conference on Alzheimer's & Parkinson's Diseases (AD/PD 2026)
SARASOTA, FLORIDA / ACCESS Newswire / March 9, 2026 / Specificity (OTCID:SPTY), a leading performance marketing agency known for its proprietary advertising technology and human verified audience targeting, today announced a surge of new client partnerships across multiple industries following a series of strategic growth initiatives previously outlined by the company. Over the past several months, Specificity has announced multiple initiatives designed to accelerate expansion, including securing strategic capital, entering the $600 billion U.S. home services market, and outlining aggressive growth plans for 2026 after achieving positive cash flow.
